A multicenter phase III randomized double-blind placebo controlled trial of pravastatin added to first-line standard chemotherapy in patients with small cell lung cancer (SCLC)

MLA

Hannah Farrant, et al. “A Multicenter Phase III Randomized Double-Blind Placebo Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Patients with Small Cell Lung Cancer (SCLC).” Journal of Clinical Oncology, vol. 31, May 2013, p. 7595. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........5854f73907696ae48f0382793b7a4695&authtype=sso&custid=ns315887.

APA

Hannah Farrant, Christian H. Ottensmeier, Kate Fife, Michael J. Seckl, C. Wadsworth, Peter Schmid, M.H. Cullen, LE James, Gary Middleton, B. Crosse, Iftekhar Khan, D Muthukumar, Joyce Thompson, Susan Harden, & Paul D. Taylor. (2013). A multicenter phase III randomized double-blind placebo controlled trial of pravastatin added to first-line standard chemotherapy in patients with small cell lung cancer (SCLC). Journal of Clinical Oncology, 31, 7595.

Chicago

Hannah Farrant, Christian H. Ottensmeier, Kate Fife, Michael J. Seckl, C. Wadsworth, Peter Schmid, M.H. Cullen, et al. 2013. “A Multicenter Phase III Randomized Double-Blind Placebo Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Patients with Small Cell Lung Cancer (SCLC).” Journal of Clinical Oncology 31 (May): 7595. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........5854f73907696ae48f0382793b7a4695&authtype=sso&custid=ns315887.